These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 36460716)
1. Reduced excitatory neuron activity and interneuron-type-specific deficits in a mouse model of Alzheimer's disease. Algamal M; Russ AN; Miller MR; Hou SS; Maci M; Munting LP; Zhao Q; Gerashchenko D; Bacskai BJ; Kastanenka KV Commun Biol; 2022 Dec; 5(1):1323. PubMed ID: 36460716 [TBL] [Abstract][Full Text] [Related]
2. Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer's disease. Hijazi S; Heistek TS; Scheltens P; Neumann U; Shimshek DR; Mansvelder HD; Smit AB; van Kesteren RE Mol Psychiatry; 2020 Dec; 25(12):3380-3398. PubMed ID: 31431685 [TBL] [Abstract][Full Text] [Related]
3. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model. Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064 [TBL] [Abstract][Full Text] [Related]
4. Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease. Dikranian K; Kim J; Stewart FR; Levy MA; Holtzman DM Int J Clin Exp Pathol; 2012; 5(6):482-95. PubMed ID: 22949930 [TBL] [Abstract][Full Text] [Related]
5. Transplantation of GABAergic Interneuron Progenitor Attenuates Cognitive Deficits of Alzheimer's Disease Model Mice. Lu MH; Zhao XY; Xu DE; Chen JB; Ji WL; Huang ZP; Pan TT; Xue LL; Wang F; Li QF; Zhang Y; Wang TH; Yanagawa Y; Liu CF; Xu RX; Xia YY; Li S; Ma QH J Alzheimers Dis; 2020; 75(1):245-260. PubMed ID: 32280096 [TBL] [Abstract][Full Text] [Related]
6. Distinct disease-sensitive GABAergic neurons in the perirhinal cortex of Alzheimer's mice and patients. Sanchez-Mejias E; Nuñez-Diaz C; Sanchez-Varo R; Gomez-Arboledas A; Garcia-Leon JA; Fernandez-Valenzuela JJ; Mejias-Ortega M; Trujillo-Estrada L; Baglietto-Vargas D; Moreno-Gonzalez I; Davila JC; Vitorica J; Gutierrez A Brain Pathol; 2020 Mar; 30(2):345-363. PubMed ID: 31491047 [TBL] [Abstract][Full Text] [Related]
7. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice. Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800 [TBL] [Abstract][Full Text] [Related]
8. The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to β-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment. Ostapchenko VG; Chen M; Guzman MS; Xie YF; Lavine N; Fan J; Beraldo FH; Martyn AC; Belrose JC; Mori Y; MacDonald JF; Prado VF; Prado MA; Jackson MF J Neurosci; 2015 Nov; 35(45):15157-69. PubMed ID: 26558786 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory Parvalbumin Basket Cell Activity is Selectively Reduced during Hippocampal Sharp Wave Ripples in a Mouse Model of Familial Alzheimer's Disease. Caccavano A; Bozzelli PL; Forcelli PA; Pak DTS; Wu JY; Conant K; Vicini S J Neurosci; 2020 Jun; 40(26):5116-5136. PubMed ID: 32439703 [TBL] [Abstract][Full Text] [Related]
10. Structural analysis of the microglia-interneuron interactions in the CA1 hippocampal area of the APP/PS1 mouse model of Alzheimer's disease. Gervais É; Iloun P; Martianova E; Gonçalves Bessa AC; Rivest S; Topolnik L J Comp Neurol; 2022 Jun; 530(9):1423-1437. PubMed ID: 34919273 [TBL] [Abstract][Full Text] [Related]
11. Neurophysiological effects of human-derived pathological tau conformers in the APPKM670/671NL.PS1/L166P amyloid mouse model of Alzheimer's disease. Tok S; Maurin H; Delay C; Crauwels D; Manyakov NV; Van Der Elst W; Moechars D; Drinkenburg WHIM Sci Rep; 2022 May; 12(1):7784. PubMed ID: 35546164 [TBL] [Abstract][Full Text] [Related]
12. Citalopram restores short-term memory deficit and non-cognitive behaviors in APP/PS1 mice while halting the advance of Alzheimer's disease-like pathology. Zhang Q; Yang C; Liu T; Liu L; Li F; Cai Y; Lv K; Li X; Gao J; Sun D; Xu H; Yang Q; Fan X Neuropharmacology; 2018 Mar; 131():475-486. PubMed ID: 29241655 [TBL] [Abstract][Full Text] [Related]
13. Dysfunction of Somatostatin-Positive Interneurons Associated with Memory Deficits in an Alzheimer's Disease Model. Schmid LC; Mittag M; Poll S; Steffen J; Wagner J; Geis HR; Schwarz I; Schmidt B; Schwarz MK; Remy S; Fuhrmann M Neuron; 2016 Oct; 92(1):114-125. PubMed ID: 27641495 [TBL] [Abstract][Full Text] [Related]
14. Blockade of adenosine A Ji Q; Yang Y; Xiong Y; Zhang YJ; Jiang J; Zhou LP; Du XH; Wang CX; Zhu ZR Alzheimers Res Ther; 2023 Oct; 15(1):187. PubMed ID: 37899431 [TBL] [Abstract][Full Text] [Related]